Description
Antimicrobial-resistant infections are predicted to become the second biggest cause of death worldwide by 2050. Despite increasing investment in the development of new antimicrobials, awareness campaigns on antimicrobial misuse and abuse, and monitoring of antimicrobial use and resistance in animals, humans and the environment, antimicrobial resistance continues to grow and the last three decades have not seen even one novel antimicrobial class reach the market. Could the answer lie in a 'Trojan horse' strategy to disrupt a natural physiological process common to all bacteria?
The copper market has recently been showing unusual instability. New EU legislation, though not always directly related, seems to be having a significant impact on copper prices. This is the case for the Chips Act and the Critical Raw Materials Act - designed to make EU industry more resilient by...
Published 10/18/24
Electrification is gaining momentum across many sectors, including transport, buildings and industry, driven by the EU's climate ambition and security of supply. As the cost of renewable energy technologies like solar and wind continues to fall, electrification presents an opportunity to reshape...
Published 09/13/24